BioNADrx Holdings, Inc. Bryleos
1 clinical trials · Sponsor
◉ Watch BioNADrx Holdings, Inc. Bryleos
| Record | Firm | Date |
|---|---|---|
| Renewal-NAD+: A Study of Oral NAD+ and Its Multi-omic Impact in a Healthy Cohort (NCT07336836) | BioNADrx Holdings, Inc. Bryleos | 2022-02-23 |
Track BioNADrx Holdings, Inc. Bryleos automatically
Every clearance here is in the API, with alerts when new ones post.